In developed communities, particularly in the US, Vegans have earned unfortunate reputations for being a little annoying. However, new scientific research suggests that they may actually have the right standpoint on the issue of meat consumption, especially for anyone who is interested in actually helping the environment. According to a recent study, going meatless is one of the best ways to save the world.
The study in question is the joint effort by Global Food Security Programme of the UK and the Seventh Framework Programme of the EU, Futurism reports. The study basically looked at what would happen if people stopped eating livestock meats and swapped them for anything else. In this case, insects were the replacements.
Without getting too lost in the idea of munching on creepy-crawlies, which have been proven to not only be nutritious but also delicious, the results of the research were pretty conclusive. Basically, if people really want to save the environment and, by extension humanity, meat consumption is going to have to drop considerably.
In the paper that the researchers published, it would seem that the meat issue isn’t the only thing at stake here, either. Since more resources come from livestock such as eggs and dairy products, drastically reducing the practice would lead to a shortage in those areas, as well.
“Animal products, i.e. meat, milk and eggs, provide an important component in global diets, but livestock dominate agricultural land use by area and are a major source of greenhouse gases,” the paper reads. “Cultural and personal associations with animal product consumption create barriers to moderating consumption, and hence reduced environmental impacts.”
This concept isn’t new, by any means. Some experts have even posited a few years ago that giving up on eating beef would have a much larger impact in the fight against climate change than giving up cars. That’s just the cows. Giving up on chickens, pork, sheep, goats, and turkey would make the effects exponentially more noticeable.


Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
NASA Resumes Cygnus XL Cargo Docking with Space Station After Software Fix
Novo Nordisk Shares Tumble After CagriSema Misses Key Trial Endpoint
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 



